A longstanding debate on health systems organization relates to benefits of integrating health programs that emphasize specific interventions into mainstream health systems to increase access and improve health outcomes This paper is organized in five chapters. This introduction is followed by...

A longstanding debate on health system organization relates to the benefits of integrating programs that emphasize specific interventions into mainstream health systems to increase access and improve health outcomes. This debate has long been characterized by polarization of views and...

The health workforce plays a key role in increasing access to health services for the poor in developing countries. Recent evidence has demonstrated an important link between staffing levels and both service delivery and health outcomes. Various global and country-level estimates have also shown...

Strategic purchasing of health services has been identified as one of the critical components for countries to progress towards achieving universal health coverage (UHC). Due to decentralized governance, there are multiple purchasers in Nigeria, which has led to fragmentation, lack of...

The health workforce plays a key role in increasing access to health services for the poor in developing countries. Recent evidence has demonstrated an important link between staffing levels and both service delivery and health outcomes. Various global and country-level estimates have also shown...

Im April 2023 nahm die Kommission Vorschläge zur Einführung eines einheitlichen ergänzenden Schutzzertifikats und eines zentralisierten Prüfverfahrens für ergänzende Schutzzertifikate für Arzneimittel an. In dieser Studie werden die möglichen Auswirkungen dieser Vorschläge auf den...

Im April 2023 nahm die Kommission Vorschläge zur Einführung eines einheitlichen ergänzenden Schutzzertifikats und eines zentralisierten Prüfverfahrens für ergänzende Schutzzertifikate für Arzneimittel an. In dieser Studie werden die möglichen Auswirkungen dieser Vorschläge auf den...

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...